Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

Journal Articles

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, Petar Antunovic, MD, Asa Rangert Derolf, MDPhD, Hege Garelius, MD, Sören Lehmann, Prof, Kristina Myhr-Eriksson, MD, Lars Möllgård, MDPhD, Bertil Uggla, MDPhD, Anders Wahlin, Prof, Lovisa Wennström, MD PhD, Martin Höglund, Ass Prof

Blood (2015) 126 (23): 4888.

https://doi.org/10.1182/blood.V126.23.4888.4888

Published: 2015

Journal Articles

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, MD, Sören Lehmann, MD PhD, Åsa Rangert Derolf, MD PhD, Lars Möllgård, MDPhD, Hege Garelius, MD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD

Blood (2014) 124 (21): 2269.

https://doi.org/10.1182/blood.V124.21.2269.2269

Published: 2014

Journal Articles

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Christer Nilsson, MD, Erik Hulegårdh, MD, Vladimir Lazarevic, MD, Hege Garelius, MD, Asa Rangert Derolf, MDPhD, Lars Möllgård, MDPhD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD, Gunnar Juliusson, MD PhD, Dick Stockelberg, MD PhD, Lehmann Soren, MD PhD

Blood (2014) 124 (21): 281.

https://doi.org/10.1182/blood.V124.21.281.281

Published: 2014

Journal Articles

Congenital dyserythropoietic anemias: molecular insights and diagnostic approach

Achille Iolascon, Hermann Heimpel, Anders Wahlin, Hannah Tamary

Blood (2013) 122 (13): 2162–2166.

https://doi.org/10.1182/blood-2013-05-468223

Published: 2013

Journal Articles

Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23

Maria Liljeholm, Andrew F. Irvine, Ann-Louise Vikberg, Anna Norberg, Stacy Month, Herbert Sandström, Anders Wahlin, Masanori Mishima, Irina Golovleva

Blood (2013) 121 (23): 4791–4799.

https://doi.org/10.1182/blood-2012-10-461392

Published: 2013

Includes: Multimedia, Supplemental data

Journal Articles

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Soren Lehmann, MD, PhD, Vladimir Lazarevic, MD, Ann-Sofi Hörstedt, Erik Hulegårdh, MD, Christer Nilsson, MD, Petar Antunovic, MD, Åsa Rangert Derolf, MD, PhD, Lars Möllgård, MD, PhD, Bertil Uggla, MD, PhD, Lovisa Vennström, MD, Anders Wahlin, MD, PhD, Martin Hoglund, MD, PhD, Dick Stockelberg, MD, PhD, Gunnar Juliusson, MD, PhD

Blood (2012) 120 (21): 130.

https://doi.org/10.1182/blood.V120.21.130.130

Published: 2012

Journal Articles

Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study

Ebba K. Lindqvist, Lynn R. Goldin, Ola Landgren, Cecilie Blimark, Ulf-Henrik Mellqvist, Ingemar Turesson, Anders Wahlin, Magnus Björkholm, Sigurdur Y. Kristinsson

Blood (2011) 118 (24): 6284–6291.

https://doi.org/10.1182/blood-2011-04-347559

Published: 2011

Includes: Supplemental data

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Sigurdur Y. Kristinsson, MD, PhD, Tang Min, PhD, Ruth Pfeiffer, PhD, Magnus Björkholm, MD, PhD, Lynn Goldin, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD

Blood (2010) 116 (21): 4053.

https://doi.org/10.1182/blood.V116.21.4053.4053

Published: 2010

Journal Articles

Copy Number Variations In Acute Leukemia with Cytogenetically Detected 11q23 Rearrangements

Irina Golovleva, Pia Lundberg, Erik Forestier, Anders Wahlin, MD, PhD

Blood (2010) 116 (21): 4835.

https://doi.org/10.1182/blood.V116.21.4835.4835

Published: 2010

Journal Articles

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study

Sigurdur Y. Kristinsson, Min Tang, Ruth M. Pfeiffer, Magnus Björkholm, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Ingemar Turesson, Ola Landgren

Blood (2010) 116 (15): 2651–2655.

https://doi.org/10.1182/blood-2010-04-282848

Published: 2010

Journal Articles

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

Sigurdur Y. Kristinsson, Ruth M. Pfeiffer, Magnus Björkholm, Lynn R. Goldin, Sam Schulman, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Ingemar Turesson, Ola Landgren

Blood (2010) 115 (24): 4991–4998.

https://doi.org/10.1182/blood-2009-11-252072

Published: 2010

Journal Articles

Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.

Gunnar Juliusson, Lars Möllgård, Sören Lehmann, MD, PhD, Åsa Rangert Derolf, M.D., Ulf Tidefelt, MD, PhD, Dick Stockelberg, MD, PhD, Mats L Brune, Vladimir Lazarevic, Petar Antunovic, Anders Wahlin, Martin Hoglund, MD, PhD

Blood (2009) 114 (22): 2289.

https://doi.org/10.1182/blood.V114.22.2289.2289

Published: 2009

Journal Articles

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Sigurdur Y Kristinsson, M.D., Ph.D., Ruth Pfeiffer, PhD, Magnus Bjorkholm, MD, PhD, Lynn R Goldin, PhD, Sam Schulman, MD, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2009) 114 (22): 1872.

https://doi.org/10.1182/blood.V114.22.1872.1872

Published: 2009

Journal Articles

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

Ola Landgren, Sigurdur Y. Kristinsson, Lynn R. Goldin, Neil E. Caporaso, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Magnus Bjorkholm, Ingemar Turesson

Blood (2009) 114 (4): 791–795.

https://doi.org/10.1182/blood-2008-12-191676

Published: 2009

Journal Articles

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Gunnar Juliusson, Petar Antunovic, Åsa Derolf, Sören Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wahlin, Martin Höglund

Blood (2009) 113 (18): 4179–4187.

https://doi.org/10.1182/blood-2008-07-172007

Published: 2009

Journal Articles

Pre-Transplant Hyperferritinemia Is Associated with Low Incidence of Chronic Gvhd, High Relapse Rate and Impaired Survival in Patients with Hematological Malignancies after Allogeneic HSCT

Hans Gustaf Hagglund, Fryderyk Lorenz, Mats Remberger, Bjorn Wahlin, Anders Wahlin

Blood (2008) 112 (11): 4299.

https://doi.org/10.1182/blood.V112.11.4299.4299

Published: 2008

Journal Articles

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Sigurdur Y Kristinsson, M.D., Magnus Bjorkholm, MD, PhD, Lynn R. Goldin, Ph.D., Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2008) 112 (11): 1678.

https://doi.org/10.1182/blood.V112.11.1678.1678

Published: 2008

Journal Articles

Increased Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Lymphoproliferative Tumors among 14689 First-Degree Relatives of 4488 MGUS Patients in Sweden.

Ola Landgren, MD, PhD, Sigurdur Y. Kristinsson, MD, Lynn R. Goldin, PhD, Neil E. Caporaso, MD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Magnus Bjorkholm, MD, PhD, Ingemar Turesson, MD, PhD

Blood (2007) 110 (11): 660.

https://doi.org/10.1182/blood.V110.11.660.660

Published: 2007

Journal Articles

Application of Risk-Adapted Therapy for Acute Myeloid Leukemia to a Population. Effects of Stem Cell Transplantation on Outcome.

Anders Wahlin, M.D., Ph.D, Mats L. Brune, M.D., Ph.D., Rolf Billstrom, M.D., Ph.D.

Blood (2004) 104 (11): 4449.

https://doi.org/10.1182/blood.V104.11.4449.4449

Published: 2004

NARROW

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Congenital dyserythropoietic anemias: molecular insights and diagnostic approach

Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Copy Number Variations In Acute Leukemia with Cytogenetically Detected 11q23 Rearrangements

Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Pre-Transplant Hyperferritinemia Is Associated with Low Incidence of Chronic Gvhd, High Relapse Rate and Impaired Survival in Patients with Hematological Malignancies after Allogeneic HSCT

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Increased Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Lymphoproliferative Tumors among 14689 First-Degree Relatives of 4488 MGUS Patients in Sweden.

Application of Risk-Adapted Therapy for Acute Myeloid Leukemia to a Population. Effects of Stem Cell Transplantation on Outcome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only